Year: 2013
Type: article
Study design: Observational Study
Abstract: Transplant recipients have elevated cancer risk including risk of human papillomavirus (HPV)-associated cancers of the cervix, anus, penis, vagina, vulva and oropharynx. We examined the incidence of HPV-related cancers in 187 649 US recipients in the Transplant Cancer Match Study. Standardized incidence ratios (SIRs) compared incidence rates to the general population, and incidence rate ratios (IRRs) compared rates across transplant subgroups. We observed elevated incidence of HPV-related cancers (SIRs: in situ 3.3-20.3, invasive 2.2-7.3), except for invasive cervical cancer (SIR 1.0). Incidence increased with time since transplant for vulvar, anal and penile cancers (IRRs 2.1-4.6 for 5+ vs. <2 years). Immunophenotype, characterized by decreased incidence with HLA DRB1:13 and increased incidence with B:44, contributed to susceptibility at several sites. Use of specific immunosuppressive medications was variably associated with incidence; for example, tacrolimus, was associated with reduced incidence for some anogenital cancers (IRRs 0.4-0.7) but increased incidence of oropharyngeal cancer (IRR 2.1). Thus, specific features associated with recipient characteristics, transplanted organs and medications are associated with incidence of HPV-related cancers after transplant. The absence of increased incidence of invasive cervical cancer highlights the success of cervical screening in this population and suggests a need for screening for other HPV-related cancers.
DOI: 10.1111/ajt.12472
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,300
Funders: Minneapolis Medical Research Foundation, National Institutes of Health, Centers for Disease Control and Prevention, Health Resources and Services Administration, National Cancer Institute, National Institute of Environmental Health Sciences, National Center for Chronic Disease Prevention and Health Promotion
Awards: SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER) EXPANSION PROGRAM, G1073836666, Surveillance, Epidemiology and End Results (SEER) Program - Iowa, G1174132558, G1196668276, G1415048017, G1541363512, G1874590579, G1932976417, G1938264392, G1997415009, G2112066787, G2155397213, G2197144220, G2238803135, #14: Residual Tissue Repository to Create HIV Cancer Tumor Tissue Microrarrays , SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM., G2557693156, G2590553186, G2925750098, G2970228389, G3161224617, G3205575695, G3349732858, G3651850380, G3660129545, G391480630, WS No. 12 Patterns of Care DX Year 2008, G413360666, G4157532208, G4315475969, G4527459645, G4641064582, G4689516008, G4843834169, G4861657729, G49039603, NATIONAL CANCER PREVENTION AND CONTROL PROGRAM, G4997880997, G5132823645, G5252745868, CALIFORNIA'S PARTICIPATION IN THE NATIONAL CANCER PREVENTION AND CONTRO PROGRAM, G5333917095, G535079399, G5546086073, G5614148151, G5909751745, G592384189, G6000163541, G610676220, G6543795044, G667355291, G6718950571, G6880417919, G6904620151, G6934787967, G6991982511, G702041046, G7033391325, G7195422766, G7278087418, G747710681, HPV: Biology, Clinical Significance and Epidemiology, G7670209639, G8014336463, G8098614320, G8359701517, G8550955980, G8598267616, Environmental Health Sciences Research Center
OpenAlex ID: W1894863068
